Resmed (RSMDF) Other Non-Current Liabilities (2010 - 2026)

Resmed (RSMDF) has reported Other Non-Current Liabilities for 17 consecutive years, with $213.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities rose 50.53% year-over-year to $213.0 million; the trailing twelve-month figure through Jun 2026 stood at $213.0 million (up 50.53% YoY), and the FY2026 full-year result was $213.0 million, up 50.53% from the prior year.
• Other Non-Current Liabilities rose to $213.0 million in Q2 2026 per RSMDF's latest filing, from $146.1 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $213.0 million in Q2 2026 and bottomed at $10.8 million in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $80.3 million across 5 years, with a median of $60.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities tumbled 85.14% in 2024, then surged 1179.09% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $50.6 million in 2022, then surged by 44.05% to $72.9 million in 2023, then sank by 85.14% to $10.8 million in 2024, then soared by 1179.09% to $138.5 million in 2025, then soared by 53.77% to $213.0 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $213.0 million, $146.1 million, and $138.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.